Ionis Pharmaceuticals’ launch of Tryngolza (olezarsen) is off to a flying start as a treatment for familial chylomicronemia syndrome (FCS). | Ionis Pharmaceuticals’ launch of Tryngolza (olezarsen) is ...

AbbVie ABBV announced that the European Commission has granted marketing approval to its blockbuster drug Rinvoq for treating giant cell arteritis (“GCA”), an autoimmune disease that causes ...

The updated indication allows the use of Rinvoq prior to the use of tumor necrosis factor blocking agents in certain patients. "At AbbVie, we are committed to addressing the ongoing needs of patients ...

(RTTNews) - Janssen-Cilag International NV, a Johnson & Johnson company, announced that the European Commission has approved a new indication for DARZALEX or daratumumab subcutaneous formulation as ...

Amgen AMGN announced that the FDA has approved its rare disease drug Uplizna (inebilizumab) for a new indication. The regulatory body has now approved Uplizna for the treatment of adults living with ...

PLAINSBORO, N.J., Aug. 15, 2025 /PRNewswire/ -- Novo Nordisk (NVO) today announced that the US Food and Drug Administration (FDA) has approved a new indication for Wegovy ® (semaglutide) injection 2.4 ...

The US Food and Drug Administration has approved two new indications for the PD-1-blocking antibody, retifanlimab-dlwr (Zynyz, Incyte), both for locally recurrent or metastatic squamous cell anal ...

Leqvio can now be used alone, without addition of statin therapy, as adjunct to diet and exercise for LDL-C reduction in patients with hypercholesterolemia (high LDL-C)1 4 out of 5 atherosclerotic ...

Latest FDA Clearance Expands to Improve the Appearance of Skin Laxity on the Anterior Arms, Posterior Arms and Abdomen, to launch in the United States before worldwide expansion. Merz Aesthetics, the ...

Four medicines received positive opinions from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) last week, expanding treatment options for cancer, rare ...